Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have earned a consensus rating of “Moderate Buy” from the four ratings firms that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average […]
More Stories
Phillips Financial Management LLC Has $2.28 Million Stock Holdings in NVIDIA Co. (NASDAQ:NVDA)
Phillips Financial Management LLC increased its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 14.6% during the...
Impact Capital Partners LLC Takes $9.96 Million Position in NVIDIA Co. (NASDAQ:NVDA)
Impact Capital Partners LLC purchased a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) during the 4th...
Lazard Freres Gestion S.A.S. Sells 211,408 Shares of NVIDIA Co. (NASDAQ:NVDA)
Lazard Freres Gestion S.A.S. decreased its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 15.2% in the...
CFO4Life Group LLC Has $4.76 Million Position in NVIDIA Co. (NASDAQ:NVDA)
CFO4Life Group LLC lifted its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 3.9% in the fourth...
NVIDIA Co. (NASDAQ:NVDA) is 1776 Wealth LLC’s 8th Largest Position
1776 Wealth LLC raised its position in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1.1% in the 4th quarter, HoldingsChannel.com...
NVIDIA Co. (NASDAQ:NVDA) Shares Acquired by Madison Wealth Partners Inc
Madison Wealth Partners Inc boosted its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1.8% in the...